Predicting Mortality in COPD with Validated and Sensitive Biomarkers; Fibrinogen and Mid-Range-Proadrenomedullin (MR-proADM)

Autor: Maaike C. Zuur-Telgen, Emanuel Citgez, Abraham T. Zuur, Paul VanderValk, Job van der Palen, Huib A. M. Kerstjens, Marjolein Brusse-Keizer

Publikováno v: COPD: Journal of Chronic Obstructive Pulmonary Disease, 18(6), 643-649. Taylor & Francis Group
COPD: Journal of Chronic Obstructive Pulmonary Disease, 18(6), 643-649. Informa Healthcare

Although fibrinogen is a FDA qualified prognostic biomarker in COPD, it still lacks sufficient resolution to be clinically useful. Next to replication of findings in different cohorts also the combination with other validated biomarkers should be inv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbde0b7c0dad27607dfbb8604da6ec0f
https://doi.org/10.1080/15412555.2021.2009791